[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 366,519
  • Shares Outstanding, K 20,205
  • Annual Sales, $ 79,180 K
  • Annual Income, $ -64,720 K
  • EBIT $ -67 M
  • EBITDA $ -59 M
  • 60-Month Beta 1.33
  • Price/Sales 4.64
  • Price/Cash Flow 12.69
  • Price/Book 2.74

Options Overview Details

View History
  • Implied Volatility 31.07% (-2.67%)
  • Historical Volatility 49.80%
  • IV Percentile 1%
  • IV Rank 8.50%
  • IV High 149.14% on 01/30/26
  • IV Low 20.10% on 06/16/26
  • Expected Move (DTE 21) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 101
  • Volume Avg (30-Day) 62
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 818
  • Open Int (30-Day) 1,324
  • Expected Range 18.20 to 18.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 05/31/26
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year $0.45
  • Growth Rate Est. (year over year) +221,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.28 +19.11%
on 05/27/26
18.57 -1.97%
on 06/16/26
+2.92 (+19.11%)
since 05/26/26
3-Month
11.09 +64.11%
on 03/30/26
18.57 -1.97%
on 06/16/26
+6.50 (+55.56%)
since 03/26/26
52-Week
11.09 +64.11%
on 03/30/26
21.01 -13.37%
on 01/23/26
+1.08 (+6.31%)
since 06/26/25

Most Recent Stories

More News
Are ACA, LPRO, SLP, ALOT Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

LPRO : 3.12 (unch)
SLP : 18.20 (+0.33%)
ALOT : 28.47 (+0.04%)
ACA : 144.50 (-0.32%)
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--SLP, FSEA, EQH, and CRBG

NEW YORK , June 24, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

SLP : 18.20 (+0.33%)
FSEA : 16.93 (+0.12%)
CRBG : 28.61 (+1.67%)
EQH : 44.00 (+0.36%)
Simulations Plus (SLP) Investigation: Investors Who Suffered Losses Encouraged to Contact Johnson Fistel

Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Simulations Plus, Inc. (NASDAQ: SLP). The investigation concerns whether Simulations...

SLP : 18.20 (+0.33%)
Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit

New capabilities connect AI agents, scientific literature, and validated computational engines to accelerate model-informed drug development

SLP : 18.20 (+0.33%)
Are ROKU, SLP, NUVL, DAN Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

DAN : 28.13 (-1.12%)
ROKU : 135.40 (+0.50%)
SLP : 18.20 (+0.33%)
NUVL : 123.52 (-0.01%)
Simulations Plus (SLP) Investigation: Investors Who Suffered Losses Encouraged to Contact Johnson Fistel

SAN DIEGO , June 22, 2026 /PRNewswire/ -- Johnson Fistel, PLLP is investigating potential securities law violations on behalf of investors of Simulations Plus, Inc. (NASDAQ: SLP). The investigation...

SLP : 18.20 (+0.33%)
Simulations Plus, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – SLP

The DJS Law Group announces that it is investigating claims on behalf of investors of Simulations Plus, Inc. (“Simulations Plus” or “the Company”) (NASDAQ: SLP ) violations...

SLP : 18.20 (+0.33%)
Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Simulations Plus ...

SLP : 18.20 (+0.33%)
Are FTHM, ALOT, SLP, ROKU Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

ROKU : 135.40 (+0.50%)
FTHM : 1.0700 (unch)
SLP : 18.20 (+0.33%)
ALOT : 28.47 (+0.04%)
SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Simulations Plus, Inc. (“Simulations Plus” or “the...

SLP : 18.20 (+0.33%)

Business Summary

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab,...

See More

Key Turning Points

3rd Resistance Point 18.29
2nd Resistance Point 18.25
1st Resistance Point 18.23
Last Price 18.20
1st Support Level 18.16
2nd Support Level 18.12
3rd Support Level 18.10

See More

52-Week High 21.01
Last Price 18.20
Fibonacci 61.8% 17.22
Fibonacci 50% 16.05
Fibonacci 38.2% 14.88
52-Week Low 11.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.